Literature DB >> 29991055

SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction.

Xiaoshuang Wei1,2, Xu Li1,2, Wei Yan1,2, Xinghua Zhang1,2, Yu Sun1,2, Feng Zhang1,2.   

Abstract

BACKGROUND/AIMS: SKP2 overexpression has been associated with poor prognosis in numerous cancers. The mechanisms of autophagy in the tumor pathogenesis have been a research focus recently. How the SKP2 involved in autophagy expresses oncogenic characteristics, especially in HCC, are largely unclear.
METHODS: The expression of SKP2 was detected by qPCR, Western blot, Immunohistochemical (IHC) and Immunofluorescence (IF) techniques. SKP2 was knocked down or overexpressed by lentivirus transfection in HCC cells. Functional assays such as CCK8 assays, transwell migration and invasion assays, and colony formation assays were performed to determine the role of SKP2 in HCC. Furthermore, autophagy was induced by glucose deprivation in HCC cells followed by monitoring of the levels and distributions of SKP2, CARM1 and AMPK.
RESULTS: Our data showed that SKP2 levels were significantly increased in HCC cell lines and HCC tissues rather than corresponding normal liver tissues, and augmented SKP2 levels were statistically correlated with tumor grade, size and metastases. By up-regulation or down-regulation of SKP2 in HCC cells, we confirmed that SKP2 encourages proliferation, migration, invasion, and colony formation. We then found that SKP2 was inhibited, CARM1 increased and AMPKα2 became activated in the nucleus under glucose deprivation induced autophagy. Moreover, we discovered that SKP2 was repressing CARM1 in the nucleus under nutrient-sufficient conditions in HCC.
CONCLUSIONS: We show that SKP2 promotes HCC progression and its nuclear functions of autophagy induction with CARM1 and AMPK, which may provide a potential target for HCC therapy.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  AMPK; Autophagy; CARM1; Hepatocellular Carcinoma; SKP2

Mesh:

Substances:

Year:  2018        PMID: 29991055     DOI: 10.1159/000491622

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

1.  The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1.

Authors:  Yajun Li; Yongming Fu; Xingwang Hu; Lunquan Sun; Daolin Tang; Ning Li; Fang Peng; Xue-Gong Fan
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

2.  Intranuclear inclusions in hepatocellular carcinoma contain autophagy-associated proteins and correlate with prolonged survival.

Authors:  Suzan Schwertheim; Daniela Westerwick; Holger Jastrow; Sarah Theurer; Christoph M Schaefer; Julia Kälsch; Dorothe Möllmann; Martin Schlattjan; Heiner Wedemeyer; Kurt Werner Schmid; Hideo A Baba
Journal:  J Pathol Clin Res       Date:  2019-04-08

3.  Skp2 modulates proliferation, senescence and tumorigenesis of glioma.

Authors:  Juan Wu; Hong-Kai Su; Zhi-Hui Yu; Shao-Yan Xi; Cheng-Cheng Guo; Zhe-Yu Hu; Yue Qu; Hai-Ping Cai; Yi-Ying Zhao; Hua-Fu Zhao; Fu-Rong Chen; Yu-Fan Huang; Shing-Shun Tony To; Bing-Hong Feng; Ke Sai; Zhong-Ping Chen; Jing Wang
Journal:  Cancer Cell Int       Date:  2020-03-06       Impact factor: 5.722

4.  New insights into intranuclear inclusions in thyroid carcinoma: Association with autophagy and with BRAFV600E mutation.

Authors:  Suzan Schwertheim; Sarah Theurer; Holger Jastrow; Thomas Herold; Saskia Ting; Daniela Westerwick; Stefanie Bertram; Christoph M Schaefer; Julia Kälsch; Hideo A Baba; Kurt W Schmid
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

5.  CDCA4 suppresses epithelial-mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy.

Authors:  Chenxin Xu; Haixia Cao; Ying Sui; Hui Zhang; Chen Shi; Jianzhong Wu; Rong Ma; Jifeng Feng
Journal:  Cancer Cell Int       Date:  2021-01-12       Impact factor: 5.722

Review 6.  The Skp2 Pathway: A Critical Target for Cancer Therapy.

Authors:  Zhen Cai; Asad Moten; Danni Peng; Che-Chia Hsu; Bo-Syong Pan; Rajeshkumar Manne; Hong-Yu Li; Hui-Kuan Lin
Journal:  Semin Cancer Biol       Date:  2020-02-01       Impact factor: 17.012

7.  Trehalose promotes the survival of random-pattern skin flaps by TFEB mediated autophagy enhancement.

Authors:  Hongqiang Wu; Huanwen Chen; Zhilong Zheng; Jiafeng Li; Jian Ding; Zihuai Huang; Chang Jia; Zitong Shen; Guodong Bao; Lingyun Wu; Abdullah Al Mamun; Huazi Xu; Weiyang Gao; Kailiang Zhou
Journal:  Cell Death Dis       Date:  2019-09-15       Impact factor: 8.469

Review 8.  F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Authors:  Dinesh Singh Tekcham; Di Chen; Yu Liu; Ting Ling; Yi Zhang; Huan Chen; Wen Wang; Wuxiyar Otkur; Huan Qi; Tian Xia; Xiaolong Liu; Hai-Long Piao; Hongxu Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

Review 9.  Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes.

Authors:  Paul Peixoto; Céline Grandvallet; Jean-Paul Feugeas; Michaël Guittaut; Eric Hervouet
Journal:  Cells       Date:  2019-12-17       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.